EUVIMEDEUVIMED entdecken
Crossref

Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies

Zafer Bulut iD, Ayşegül Karaküçük-Iyidoğan iD, Melike Bilge, Yusuf Sicak iD, Zeynep Dilan Turgut-Solak iD, Emine Elçin Oruç-Emre iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Zafer Bulut und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Arts and Sciences, Gaziantep University, Gaziantep, 27310, Türkiye. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Thiourea, Drug Design, Benzylamines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: This study was funded by the Scientific and Technological Research Council of Türkiye (TUBITAK) with project number 222Z293..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A detailed analysis of the research on the treatment of Alzheimer's disease indicates that selective inhibition of butyrylcholinesterase (BChE) is the most promising strategy for identifying a drug target. According to this perspective, in this study, a new series of potential BChE inhibitors ( 1a–8a and 1b–8b ) were designed using a structure‐based design approach and synthesized as enantiomer pairs based on the benzyl thiourea attached to a chiral moiety. The in vitro anticholinesterase activity studies against acetylcholinesterase (AChE) and BChE consistently demonstrated that the majority of the designed compounds exhibited selective and potent BChE inhibition. Also, the present results of the study reveal that compound 6b , which has a methyl group at the para position of the phenyl ring and has an S configuration, was the most potent compound against BChE with an IC 50 value of 1.46 ± 1.99 μM ( SI = 8.47). In contrast, the chiral thioureas ( 8a and 8b ) bearing a cyclohexyl group demonstrated higher selectivity toward AChE, with SI values of 2.10 and 2.32, respectively. Notably, compounds 2a and 2b showed dual inhibitory effects with similar potency for AChE and greater potency for BChE, compared to the standard drug galantamine. The molecular docking method, which showed a good correlation with our in vitro anticholinesterase activity results, was used to predict the interactions of all chiral thioureas within the binding pockets of AChE and BChE. Further structural improvement of these molecules in future studies may lead to the emergence of more potent AChE and BChE inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsThioureaDrug DesignBenzylaminesStructure-Activity RelationshipButyrylcholinesteraseAcetylcholinesteraseStereoisomerismMolecular Docking SimulationMolecular StructureHumansDose-Response Relationship, DrugAnimalsComputer Simulation

Stichwörter der Autor:innen

acetylcholinesterasebutyrylcholinesterasechiral thioureamolecular docking

Substanzen

Cholinesterase InhibitorsThioureaButyrylcholinesteraseAcetylcholinesteraseBenzylamines

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Arts and Sciences, Gaziantep University, Gaziantep, 27310, Türkiye.
  • Department of Chemistry, Graduate School of Natural and Applied Sciences, Gaziantep University, Gaziantep, 27310, Türkiye.
  • Department of Medicinal and Aromatic Plants, Köyceğiz Vocational School, Muğla Sıtkı Koçman University, Muğla, 48800, Türkiye.
  • Department of Bioinformatics, Institute of Health Sciences, Karadeniz Technical University, Trabzon, 61080, Türkiye.

ORCID-Profile: Zafer Bulut, Ayşegül Karaküçük-Iyidoğan, Yusuf Sicak, Zeynep Dilan Turgut-Solak, Emine Elçin Oruç-Emre

Förderung

  • This study was funded by the Scientific and Technological Research Council of Türkiye (TUBITAK) with project number 222Z293.

Zitieren

APA

Bulut, Z., Karaküçük-Iyidoğan, A., Bilge, M., Sicak, Y., Turgut-Solak, Z. D., & Oruç-Emre, E. E. (2025). Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70124

Vancouver

Bulut Z, Karaküçük-Iyidoğan A, Bilge M, Sicak Y, Turgut-Solak ZD, Oruç-Emre EE. Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70124

BibTeX
@article{Bulut2025,
  author = {Bulut, Zafer and Karaküçük-Iyidoğan, Ayşegül and Bilge, Melike and Sicak, Yusuf and Turgut-Solak, Zeynep Dilan and Oruç-Emre, Emine Elçin},
  title = {Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70124}
}
Kostenlos starten →